JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

Stryker Corp

Closed

SectorHealthcare

376.65 -0.28

Overview

Share price change

24h

Current

Min

374.8

Max

378.97

Key metrics

By Trading Economics

Income

884M

1.5B

Sales

156M

6B

P/E

Sector Avg

49.999

34.393

EPS

3.13

Dividend yield

0.88

Profit margin

25.54

Employees

53,000

EBITDA

179M

1B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+15% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.88%

2.54%

Next Earnings

28 Oct 2025

Next Dividend date

31 Oct 2025

Next Ex Dividend date

30 Sept 2025

Market Stats

By TradingEconomics

Market Cap

-7.3B

146B

Previous open

376.93

Previous close

376.65

News Sentiment

By Acuity

40%

60%

131 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

Stryker Corp Chart

Past performance is not a reliable indicator of future results.

Related News

31 Jul 2025, 20:42 UTC

Earnings

Stryker Lifts Guidance on Improving Tariff Outlook

1 May 2025, 20:56 UTC

Earnings

Stryker Lowers Adjusted EPS View on $200 Million Tariff Impact

28 Jan 2025, 21:55 UTC

Earnings

Stryker Sees Further Organic Sales Growth in 2025

28 Jan 2025, 21:46 UTC

Acquisitions, Mergers, Takeovers

Stryker to Sell Spinal Implants Business to Viscogliosi Brothers

31 Jul 2025, 20:09 UTC

Earnings

Stryker Estimates Net Impact From Tariffs in 2025 of Approximately $175M

31 Jul 2025, 20:09 UTC

Earnings

Stryker Sales >SYK

31 Jul 2025, 20:09 UTC

Earnings

Stryker Sees FY25 Organic Net Sales Up 9.5%-10%

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q Sales $6B >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q Net $884M >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker Sees FY Adj EPS $13.40-Adj EPS $13.60 >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q EPS $2.29 >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q Adj EPS $3.13 >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q Sales $6B >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q EPS $2.29 >SYK

31 Jul 2025, 20:05 UTC

Earnings

Stryker 2Q EPS $2.29 >SYK

1 May 2025, 20:41 UTC

Earnings

Stryker Lowers Adjusted EPS View on $200M Tariff Impact

1 May 2025, 20:11 UTC

Earnings

Stryker Cuts FY25 View To Adj EPS $13.20-Adj EPS $13.45 >SYK

1 May 2025, 20:10 UTC

Earnings

Stryker Raising FY25 Organic Net Sales Growth Guidance Range to 8.5% to 9.5% >SYK

1 May 2025, 20:05 UTC

Earnings

Stryker 1Q Adj EPS $2.84 >SYK

1 May 2025, 20:05 UTC

Earnings

Stryker 1Q Net $654M >SYK

1 May 2025, 20:05 UTC

Earnings

Stryker 1Q EPS $1.69 >SYK

1 May 2025, 20:05 UTC

Earnings

Stryker 1Q Sales $5.87B >SYK

1 May 2025, 20:05 UTC

Earnings

Stryker 1Q EPS $1.69 >SYK

19 Feb 2025, 13:53 UTC

Acquisitions, Mergers, Takeovers

Stryker Files 8K - Asset Acquisition Or Disposition >SYK

19 Feb 2025, 13:30 UTC

Acquisitions, Mergers, Takeovers

Stryker Completes Acquisition Of Inari Medical, Inc., Providing Entry Into The High-growth Peripheral Vascular Segment >SYK

28 Jan 2025, 21:09 UTC

Acquisitions, Mergers, Takeovers

Stryker: Transaction Is Expected to Close in the U.S. in 1H 2025 >SYK

28 Jan 2025, 21:09 UTC

Acquisitions, Mergers, Takeovers

Stryker: Agreement Includes Binding Offer to Acquire Stryker's Spinal Implants Business in France >SYK

28 Jan 2025, 21:08 UTC

Acquisitions, Mergers, Takeovers

Stryker: After Closing, VB Spine Will Become a Strategic Partner to Stryker With Exclusive Access to Mako Spine and Copilot for Use With VB Spine's Implants in Spine Procedures >SYK

28 Jan 2025, 21:08 UTC

Acquisitions, Mergers, Takeovers

Stryker: Agreement to Sell U.S. Spinal Implants Business to Viscogliosi Brothers, LLC to Create Newly Formed Co Called VB Spine, LLC >SYK

28 Jan 2025, 21:06 UTC

Earnings

Stryker Sees Organic Net Sales Growth of 8% to 9% for 2025 >SYK

Peer Comparison

Price change

Stryker Corp Forecast

Price Target

By TipRanks

15% upside

12 Months Forecast

Average 434.21 USD  15%

High 456 USD

Low 407 USD

Based on 17 Wall Street analysts offering 12 month price targets forStryker Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

17 ratings

13

Buy

4

Hold

0

Sell

Technical Score

By Trading Central

373.92 / 383.99Support & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

131 / 374 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.